PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTS
- 1 April 1988
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 331 (8592), 955-960
- https://doi.org/10.1016/s0140-6736(88)91778-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Reflections on the Efficacy of Pertussis VaccinesClinical Infectious Diseases, 1987
- Pertussis vaccine: present status and future prospectsVaccine, 1985
- The concept of pertussis as a toxin-mediated diseaseThe Pediatric Infectious Disease Journal, 1984
- SYMPTOMS AFTER PRIMARY IMMUNISATION WITH DTP AND WITH DT VACCINEThe Lancet, 1984
- DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPANThe Lancet, 1984
- Efficacy of pertussis vaccination in England. Report from the PHLS Epidemiological Research Laboratory and 21 area health authorities.BMJ, 1982
- Pertussis in the United States, 1979: A Look at Vaccine EfficacyThe Journal of Infectious Diseases, 1981
- Effect of vaccination on severity and dissemination of whooping cough.BMJ, 1981
- Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964BMJ, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958